Home

Steven Michael Oliveira

CIK 1358629 · last filed 2021-12-09

Steven Michael Oliveira is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider bought $1.5M of BNTC on Dec 9, 2021. Across all open-market trades the lifetime net is −$644.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $665.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$665.5K

Companies

3

Total Filings

8

Lifetime Open-Market Net

-$644.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BNTC 10%+ Owner 55,971 $11.89 $665.5K $1.50M 1 2021-12-09
Forte Biosciences, Inc. (TOCA) Delisted 10%+ Owner 191,563 — — $176.2K 2 2020-04-14
IGC Pharma, Inc. (IGC.WS) Delisted 10%+ Owner 2,309,207 — — -$2.32M 5 2009-05-27

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-12-09 BNTC Buy (P) +331,877 $1.50M EDGAR
2020-04-14 Forte Biosciences, Inc. (TOCA) Delisted Buy (P) +74,301 $88.4K EDGAR
2020-03-03 Forte Biosciences, Inc. (TOCA) Delisted Buy (P) +65,149 $87.8K EDGAR
2009-05-27 IGC Pharma, Inc. (IGC.WS) Delisted Conv (C) +151,234 $0 EDGAR
2009-05-21 IGC Pharma, Inc. (IGC.WS) Delisted Sell (S) −423,986 -$410.8K EDGAR
2009-05-20 IGC Pharma, Inc. (IGC.WS) Delisted Sell (S) −1,113,025 -$1.32M EDGAR
2008-10-02 IGC Pharma, Inc. (IGC.WS) Delisted Buy (P) +200,000 $0 EDGAR
2008-03-11 IGC Pharma, Inc. (IGC.WS) Delisted Mixed −145,800 -$590.5K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.